Browsing: Cognitive/neurodegenerative disorders
New research highlights the creation of a six-layered 3D printed structure that mimics the structure of brain tissue.
Recently developed monoclonal antibodies have been demonstrated to successfully target toxic oligomer proteins in both Alzheimer’s and Parkinson’s disease.
Several challenges still remain for the accurate diagnosis of dementia in individuals with Down’s Syndrome even following 40 years of focused research. This review looks at current research to identify genetic and biological measures of Alzheimer’s disease in Down’s Syndrome.
This study investigates the use of five neuropsychological tests to predict cognitive decline.
An early precursor of the amyloid beta peptide, ßCTF, has been found to initiate a number of processes that can lead to the loss of neurons critical for memory formation in early Alzheimer’s disease.
This article discusses the role of the FAD-dependent lysine specific demethylase, KDM1, in brain function, and consequently its potential use as a target for treatments for neurodegenerative disease.
Solanezumab shows potential efficacy for preventing disease progression in early-stage Alzheimer’s disease.
This article evaluates the recent evidence surrounding the possible interrelationship between Alzheimer’s disease and epilepsy and looks to its possible use in the clinic.